Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: TREATMENT OF PD-L1-NEGATIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: USE OF ANTI-CTLA-4 ANTIBODIES WITH ENHANCED ADCC TO ENHANCE IMMUNE RESPONSE TO A VACCINE Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: ANTIBODIES AGAINST TIM3 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: PROCESS FOR THE PREPARATION OF A CYCLIC DINUCLEOTIDE Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: SUBSTITUTED THIENOPYRROLES AS PAD4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: SYNTHETIC PROCESS Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: METHODS OF MEASURING HYDROPHOBICITY OF CHROMATOGRAPHIC RESINS Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: ANTIBODIES MODIFIED FOR TRANSGLUTAMINASE CONJUGATION, CONJUGATES THEREOF, AND METHODS AND USES Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: BARCODED PEPTIDE-MHC COMPLEXES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: CLASSIFYING PHARMACOVIGILANCE DOCUMENTS USING IMAGE ANALYSIS Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: DEVICES AND SYSTEMS FOR DELIVERY OF COMBINATION THERAPIES Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: FGF-21 CONJUGATE FORMULATIONS Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: ANTIBODY COMPRISING A GLUTAMINE-CONTAINING LIGHT CHAIN C-TERMINAL EXTENSION, CONJUGATES THEREOF, AND METHODS AND USES Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING Filling date: 6 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHOD OF TREATING LUNG CANCER Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHODS FOR THE SELECTION OF BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: ANTI-IDO ANTIBODY AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: SYNTHETIC PROCESSES FOR THE PRODUCTION OF 1-((3S,4R)-4-(2,6-DIFLUORO-4-METHOXYPHENYL)-2-OXOPYRROLIDIN-3-YL)-3-PHENY- LUREA Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: SUBSTITUTED INDOLE DIMER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: ANTI-MERTK ANTIBODIES FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: PET-IMAGING IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: HANDHELD MEDICAMENT DISPENSER Filling date: 6 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: MULTICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3 Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Miniaturized Dystrophins Having Spectrin Fusion Domains and Uses Thereof Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Combination Therapy for Melanoma Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Showing 50 to 100 of 438 patents.